Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inherited platelet disorders.

Catherine P M Hayward1

  • 1McMaster University and the Hamilton Regional Laboratory Medicine Program, 1200 Main Street West, HSC Room 2N31, Hamilton, ON L8N 3Z5, Canada. haywrdc@mcmaster.ca

Current Opinion in Hematology
|August 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigator-Led Research to Improve the Diagnostic Assessment of Platelet Function Disorders: Reflections on the Challenges and Rewards.

International journal of laboratory hematology·2026
Same author

When it's not Glanzmann thrombasthenia or Bernard-Soulier syndrome: diagnosing other qualitative platelet disorders.

Hematology. American Society of Hematology. Education Program·2025
Same author

Laboratory diagnosis of congenital and acquired coagulopathies, including challenging-to-diagnose rare bleeding disorders.

Pathology·2025
Same author

How Trustworthy is Light Transmittance Platelet Aggregometry With Low Platelet Count Samples? Insights From Test Replicates and Retrospective Analysis of Several Decades of Diagnostic Samples.

International journal of laboratory hematology·2025
Same author

Case Report: Tranexamic Acid Therapy Corrects the Impaired Epinephrine Aggregation Responses of Quebec Platelet Disorder.

International journal of laboratory hematology·2025
Same author

Vitamin K Deficiency: Diagnosis and Management.

Annals of laboratory medicine·2025
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Inherited platelet disorders cause bleeding by affecting platelet number or function. This review covers their types, genetics, and current management strategies.

Area of Science:

  • Hematology
  • Genetics
  • Internal Medicine

Background:

  • Inherited platelet disorders are a significant cause of bleeding disorders.
  • These conditions affect platelet quantity or quality, leading to impaired hemostasis.

Purpose of the Study:

  • To provide a comprehensive overview of inherited platelet disorders.
  • To summarize current knowledge on their clinical and laboratory features.
  • To discuss molecular genetic causes and therapeutic approaches.

Main Methods:

  • Literature review of inherited platelet disorders.
  • Synthesis of information on clinical presentation, diagnostics, and genetics.
  • Compilation of current treatment modalities.

Main Results:

Related Experiment Videos

  • Detailed classification of various inherited platelet disorders.
  • Explanation of the link between genetic defects and platelet dysfunction.
  • Overview of available and emerging therapies.

Conclusions:

  • Accurate diagnosis and understanding of molecular basis are crucial for effective management.
  • Therapeutic strategies aim to control bleeding and improve quality of life.
  • Ongoing research is vital for advancing treatment options.